SM
Suresh Mittal
About Suresh Mittal
Data last updated:
Suresh Mittal is a Director at Livewort Labs Private Limited (since 2019), Director at Jydem Bio Pharma Private Limited (since 2020) and Director at Apto Lifecare Private Limited (since 2026), and holds 3 more current directorships. The companies operate in Pharma, Manufacturing and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹2.42 Cr; the largest is Livewort Labs Private Limited at ₹1.58 Cr (FY 2024). Earlier, Suresh Mittal was a Director at Winner Nippon Leatherette Private Limited (2007–2016) and Director at Raglan Infrastructure Private Limited (2011–2016) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Oct 2019 | 2019 | ₹1.58 Cr (FY 2024) | Active | |
| Director | 02 Nov 2020 | 2017 | ₹83.8 Lakh (FY 2024) | Active | |
| Director | 16 Jul 2026 | 2026 | Active | ||
| Director | 18 Nov 2021 | 2021 | Active | ||
| Director | 11 Mar 2019 | 2019 | Active | ||
| Director | 06 Sep 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jan 2007 | 1995 | ₹58.45 Cr (FY 2025) | Active | |
| Director | 21 Mar 2011 | 1998 | ₹58.47 Cr (FY 2025) | Active | |
| Additional Director | 24 Jan 2007 | 2003 | Active | ||
| Director | 20 Feb 2007 | 2001 | ₹7.4 Lakh (FY 2022) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suresh Mittal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sanjay Kumar Garg | 02756187 | Livewort Labs Private Limited , Vlead Labs Private Limited and 1 more | Director |
| Viney Verma | 08826854 | Jydem Bio Pharma Private Limited | Director |
| Sumit Bansal | 11830805 | Apto Lifecare Private Limited | Director |
| Ritu Mittal | 07984254 | Oraxon Bio Pharma Private Limited | Director |
| Ram Gopal | 07033186 | Vlead Labs Private Limited | Director |
| Vishav Bhushan Verma | 07980137 | Vlead Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Mittal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Mittal
Suresh Mittal currently holds 6 directorships: Livewort Labs Private Limited (Director, since 07 Oct 2019, revenue ₹1.58 Cr (FY 2024)); Jydem Bio Pharma Private Limited (Director, since 02 Nov 2020, revenue ₹83.8 Lakh (FY 2024)); Apto Lifecare Private Limited (Director, since 16 Jul 2026); Oraxon Bio Pharma Private Limited (Director, since 18 Nov 2021); Vlead Labs Private Limited (Director, since 11 Mar 2019); and 1 more.
Suresh Mittal was first appointed on 24 Jan 2007 as Additional Director at Arpan Vinyls Private Limited. The most recent appointment on record is 16 Jul 2026 at Apto Lifecare Private Limited.
The 2 current companies of Suresh Mittal that report revenue have a combined latest revenue of ₹2.42 Cr: Livewort Labs Private Limited ₹1.58 Cr (FY 2024); Jydem Bio Pharma Private Limited ₹83.8 Lakh (FY 2024).
Suresh Mittal held 4 earlier board appointments: Winner Nippon Leatherette Private Limited (Director, 25 Jan 2007 to 01 Jan 2016); Raglan Infrastructure Private Limited (Director, 21 Mar 2011 to 01 Jan 2016); Arpan Vinyls Private Limited (Additional Director, 24 Jan 2007 to 25 Jul 2007); Raglan Developers Private Limited (Director, 20 Feb 2007 to 28 Sep 2012).
The current boards of Suresh Mittal's companies include Sanjay Kumar Garg (Livewort Labs Private Limited), Viney Verma (Jydem Bio Pharma Private Limited), Sumit Bansal (Apto Lifecare Private Limited), Ritu Mittal (Oraxon Bio Pharma Private Limited), Ram Gopal (Vlead Labs Private Limited), Vishav Bhushan Verma (Vlead Labs Private Limited).